Hypoalbuminemia
Showing 51 - 75 of 2,123
MGMT-unmethylated Glioblastoma (GBM), GBM Trial in New York (Nivolumab, Ipilimumab, Radiation Therapy (RT))
Completed
- MGMT-unmethylated Glioblastoma (GBM)
- GBM
- Nivolumab
- +2 more
-
New York, New YorkNew York University School of Medicine
Jun 30, 2022
Breast Cancer Trial in Cincinnati, Houston (Docetaxel, Carboplatin)
Active, not recruiting
- Breast Cancer
-
Cincinnati, Ohio
- +2 more
Apr 6, 2022
Albumin Infusion on Oxidative Albumin Modification, Albumin
Active, not recruiting
- Decompensated Cirrhosis
- Human albumin
-
Graz, AustriaDepartment of Internal Medicine, Medical University of Graz
Feb 23, 2022
Hairy Cell Leukemia Trial run by the NCI (Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin)
Active, not recruiting
- Hairy Cell Leukemia
- Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 13, 2022
Cardiac Rehabilitation Trial (Home-based mobile guided exercise-based cardiac rehabilitation, Routine Care)
Not yet recruiting
- Cardiac Rehabilitation
- Home-based mobile guided exercise-based cardiac rehabilitation
- Routine Care
- (no location specified)
Aug 10, 2023
Multiple Myeloma Trial in New York (carfilzomib, Dexamethasone, Clarithromycin)
Active, not recruiting
- Multiple Myeloma
- carfilzomib
- +3 more
-
New York, New YorkWeill Cornell Medical College
Apr 10, 2022
Hepatitis C Trial (Zinc Supplement)
Not yet recruiting
- Hepatitis C
- Zinc Supplement
- (no location specified)
Jul 16, 2022
Previously Untreated Peripheral T-cell Lymphoma Trial in Tampa, Saint Louis, New York (CC-486 Administration, CHOP
Active, not recruiting
- Previously Untreated Peripheral T-cell Lymphoma
- CC-486 Administration
- CHOP Administration
-
Tampa, Florida
- +3 more
Jan 18, 2023
Long COVID-19 on Patients With Chronic Liver Disease
Not yet recruiting
- COVID-19
- liver function , prothrombin time , INR , US .
- (no location specified)
Aug 9, 2021
Adenocarcinoma of the Gastroesophageal Junction, Diffuse Adenocarcinoma of the Stomach, Intestinal Adenocarcinoma of the Stomach
Active, not recruiting
- Adenocarcinoma of the Gastroesophageal Junction
- +12 more
- copper Cu 64-DOTA-trastuzumab
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 17, 2022
Age-Related Frailty Trial in Santa Monica (Therapeutic Plasma Exchange (TPE))
Enrolling by invitation
- Age-Related Frailty
- Therapeutic Plasma Exchange (TPE)
-
Santa Monica, CaliforniaNeurological Associates - The Interventional Group
Apr 11, 2022
Cancer, Nutrition Related Cancer, Malnutrition Trial in Madrid (Flavoured Oral Nutritional Supplement (ONS))
Completed
- Cancer
- +2 more
- Flavoured Oral Nutritional Supplement (ONS)
-
Madrid, SpainBricia Lopez Plaza
Aug 2, 2022
Multiple Myeloma Trial in Pawtucket, Providence (Ixazomib, Cyclophosphamide, Dexamethasone)
Active, not recruiting
- Multiple Myeloma
- Ixazomib
- +2 more
-
Pawtucket, Rhode Island
- +2 more
Jul 21, 2022
Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7 Trial in
Completed
- Stage III Cutaneous Melanoma AJCC v7
- +5 more
- Aldesleukin
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 17, 2022
Melanoma Trial in Providence (Ipilumumab, Nivolumab)
Active, not recruiting
- Melanoma
-
Providence, Rhode IslandRhode Island Hospital and The Miriam Hospital
Feb 24, 2022
Adult Acute Myeloid Leukemia in Remission, Recurrent Adult Acute Myeloid Leukemia Trial in Aurora, Columbus (PF-04449913)
Completed
- Adult Acute Myeloid Leukemia in Remission
- Recurrent Adult Acute Myeloid Leukemia
-
Aurora, Colorado
- +1 more
Dec 30, 2021
Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in New York (NY-ESO-1 peptide vaccine)
Completed
- Fallopian Tube Cancer
- +2 more
- NY-ESO-1 peptide vaccine
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Oct 3, 2022
Non-Transitional Cell Carcinoma of the Urothelial Tract, Small Cell of the Bladder, Adenocarcinoma of the Bladder Trial in
Completed
- Non-Transitional Cell Carcinoma of the Urothelial Tract
- +4 more
- durvalumab and tremelimumab
-
Basking Ridge, New Jersey
- +3 more
Nov 3, 2021
Cholangiocarcinoma, Stage III Gallbladder Cancer AJCC v7, Stage IIIA Gallbladder Cancer AJCC v7 Trial in Scottsdale, Rochester
Active, not recruiting
- Cholangiocarcinoma
- +6 more
- Laboratory Biomarker Analysis
- Trifluridine/Tipiracil Hydrochloride Combination Agent TAS-102
-
Scottsdale, Arizona
- +1 more
Jan 4, 2023
Idiopathic Nephrotic Syndrome Trial in United States (Standard of Care, UrApp)
Recruiting
- Idiopathic Nephrotic Syndrome
- Standard of Care
- UrApp
-
Atlanta, Georgia
- +3 more
Jul 14, 2022
Kaposi Sarcoma, Human Immunodeficiency Virus, Immune Reconstitution Syndrome Trial in Mexico city (Valganciclovir,
Completed
- Kaposi Sarcoma
- +2 more
- Valganciclovir
- Antiretroviral Combinations
-
Mexico city, MexicoInstituto Nacional de Cancerologia
Nov 23, 2021
Head and Neck Squamous Cell Carcinoma Trial in Norfolk, Omaha (Capecitabine, Docetaxel, Quality-of-Life Assessment)
Terminated
- Head and Neck Squamous Cell Carcinoma
- Capecitabine
- +3 more
-
Norfolk, Nebraska
- +2 more
Aug 10, 2022
Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma, Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma, Ann
Completed
- Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma
- +11 more
- Laboratory Biomarker Analysis
- +2 more
-
Mountain View, California
- +90 more
Aug 3, 2022